IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 217 filers reported holding IMMUNOGEN INC in Q2 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $439,123 | -61.2% | 114,355 | -49.9% | 0.00% | -66.7% |
| Q4 2022 | $1,132,938 | +0.3% | 228,415 | -3.3% | 0.00% | +50.0% |
| Q3 2022 | $1,129,000 | -73.4% | 236,200 | -54.8% | 0.00% | -89.5% |
| Q1 2021 | $4,237,000 | +609.7% | 523,087 | +199.0% | 0.02% | +216.7% |
| Q1 2020 | $597,000 | +2.6% | 174,919 | +53.5% | 0.01% | +50.0% |
| Q4 2019 | $582,000 | +85.4% | 113,932 | -21.2% | 0.00% | +33.3% |
| Q2 2019 | $314,000 | -75.0% | 144,493 | -44.8% | 0.00% | -76.9% |
| Q4 2018 | $1,256,000 | – | 261,608 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |